BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25238891)

  • 1. The overactive bladder progression to underactive bladder hypothesis.
    Chancellor MB
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S23-7. PubMed ID: 25238891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is coexistent overactive-underactive bladder (with or without detrusor overactivity and underactivity) a real clinical syndrome? ICI-RS 2019.
    Mancini V; Tarcan T; Serati M; Wyndaele M; Carrieri G; Abrams P
    Neurourol Urodyn; 2020 Jul; 39 Suppl 3():S50-S59. PubMed ID: 32032454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of underactive bladder.
    Ko KJ; Lee CU; Lee KS
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S75-S81. PubMed ID: 29279879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of underactive bladder.
    Chang YH; Siu JJ; Hsiao PJ; Chang CH; Chou EC
    J Formos Med Assoc; 2018 Mar; 117(3):178-184. PubMed ID: 28969876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives.
    Wang J; Ren L; Liu X; Liu J; Ling Q
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure of Underactive and Overactive Bladder Symptoms in Women by 1,671 Apical Sling Operations Gives Fresh Insights into Pathogenesis and Need for Definition Change.
    Liedl B; Goeschen K; Yassouridis A; Inoue H; Abendstein B; Müller-Funogea IA; Caliskan A
    Urol Int; 2019; 103(2):228-234. PubMed ID: 31185473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.
    Liu Z; Uchiyama T; Sakakibara R; Yamamoto T
    Int Urol Nephrol; 2015 May; 47(5):751-7. PubMed ID: 25792006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underactive bladder in women: is there any evidence?
    Cohn JA; Brown ET; Kaufman MR; Dmochowski RR; Reynolds WS
    Curr Opin Urol; 2016 Jul; 26(4):309-14. PubMed ID: 26927630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underactive Bladder; Review of Progress and Impact From the International CURE-UAB Initiative.
    Chancellor MB; Bartolone SN; Lamb LE; Ward E; Zwaans BMM; Diokno A
    Int Neurourol J; 2020 Mar; 24(1):3-11. PubMed ID: 32252181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction.
    Yang TH; Chuang FC; Kuo HC
    PLoS One; 2018; 13(6):e0198764. PubMed ID: 29924821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and urodynamic characteristics of underactive bladder: Data analysis of 1726 cases from a single center.
    Li X; Liao LM; Chen GQ; Wang ZX; Lu TJ; Deng H
    Medicine (Baltimore); 2018 Jan; 97(3):e9610. PubMed ID: 29504988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding underactive bladder: a review of the contemporary literature.
    Santos-Pereira M; Charrua A
    Porto Biomed J; 2020; 5(4):e070. PubMed ID: 32734011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing challenges in underactive bladder: recommendations and insights from the Congress on Underactive Bladder (CURE-UAB).
    Dewulf K; Abraham N; Lamb LE; Griebling TL; Yoshimura N; Tyagi P; Veerecke A; Bartolone SN; Zwaans BMM; De Ridder D; Diokno A; Chancellor MB
    Int Urol Nephrol; 2017 May; 49(5):777-785. PubMed ID: 28233085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of the underactive bladder.
    Aizawa N; Igawa Y
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S82-S89. PubMed ID: 29279880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of refractory overactive bladder.
    Chen LC; Kuo HC
    Low Urin Tract Symptoms; 2019 Sep; 11(4):177-181. PubMed ID: 30900373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatments available for the management of underactive bladder in neurological conditions.
    Ladi-Seyedian SS; Nabavizadeh B; Sharifi-Rad L; Kajbafzadeh AM
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):193-204. PubMed ID: 29202586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder.
    Latini JM; Giannantoni A
    Expert Opin Pharmacother; 2011 May; 12(7):1017-27. PubMed ID: 21473706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic bladder dysfunction progresses from an overactive to an underactive phenotype in a type-1 diabetic mouse model (Akita female mouse) and is dependent on NLRP3.
    Hughes FM; Allkanjari A; Odom MR; Jin H; Purves JT
    Life Sci; 2022 Jun; 299():120528. PubMed ID: 35381220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do we make progress in phenotyping patients with lower urinary tract such as overactive bladder and underactive detrusor, including using urine markers and microbiome data, to personalize therapy? ICI-RS 2023-Part 2.
    Finazzi Agrò E; Rosato E; Wagg A; Sinha S; Fede Spicchiale C; Serati M; Mancini V; de Rijk M; Tarcan T; Wein A; Abrams P; Bou Kheir G
    Neurourol Urodyn; 2024 Jan; ():. PubMed ID: 38178629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnostic criteria for detrusor underactivity: A report from the Japanese Continence Society working group on underactive bladder.
    Yoshida M; Sekido N; Matsukawa Y; Yono M; Yamaguchi O
    Low Urin Tract Symptoms; 2021 Jan; 13(1):13-16. PubMed ID: 33029933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.